Cannabis finance news

Altum calls on prescribers to ‘back compliant firms’ after losses double

by Steve Jones December 3, 2025December 4, 2025

Kind Medical parent, Altum International, saw losses double in FY25 as its chief executive urged prescribers […]

Cannim gets stay of execution as potential buyer moves in

by Steve Jones December 3, 2025December 4, 2025

Chinese investor behind Y Cannabis poised to take full control of Tasmanian Botanics in A$31m deal

by Adam Sheldon December 2, 2025December 4, 2025

InhaleRx locks in A$1m cap raise and reveals plans to rebrand

by Adam Sheldon December 1, 2025February 21, 2026

Biortica formally ends RTO bid and targets ASX listing in early 2026

by Steve Jones November 27, 2025December 4, 2025

Debt-laden Cannim poised for liquidation as potential buyers walk away

by Steve Jones November 27, 2025December 2, 2025

‘Offer us a fair price’: Thailand calls on Australia to stop driving down the cost of flower

by Steve Jones November 20, 2025November 20, 2025

Roby Zomer

Argent BioPharma secures A$11m facility to complete AusCann acquisition

by Adam Sheldon November 17, 2025February 21, 2026

ECS Botanics completes A$1.95m raise to boost product and export plans

by Adam Sheldon November 13, 2025February 21, 2026

Creditor claims in the multi millions as Cannim sale process continues

by Adam Sheldon November 13, 2025November 17, 2025